Cargando…
Negative Correlation between Placental Growth Factor and Endocan-1 in Women with Preeclampsia
Objective To analyze endocan-1, a biomarker of vascular endothelial related pathologies, and the placental growth factor (PlGF), an angiogenic factor and a placental dysfunction marker in patients with preeclampsia (PE). Methods Case-control study conducted at Hospital São Lucas, in the city of Port...
Autores principales: | Hentschke, Marta Ribeiro, da Cunha Filho, Edson Vieira, Vieira, Matias Costa, Paula, Letícia Germany, Mistry, Hiten D., Costa, Bartira Ercília Pinheiro da, Poli-de-Figueiredo, Carlos Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Revinter Publicações Ltda
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316888/ https://www.ncbi.nlm.nih.gov/pubmed/30352456 http://dx.doi.org/10.1055/s-0038-1670713 |
Ejemplares similares
-
Immature Platelet Fraction and Thrombin Generation: Preeclampsia Biomarkers
por: Moraes, Daniela, et al.
Publicado: (2022) -
Are Endocan Plasma Levels Altered in Preeclampsia?
por: Lopes, Ana Cristina dos Santos, et al.
Publicado: (2021) -
Patients undergoing elective and oncofertility preservation respond similarly to controlled ovarian stimulation for fertility preservation
por: Kira, Ariane Tieko Frare, et al.
Publicado: (2022) -
Circulating endocan and preeclampsia: a meta-analysis
por: Lan, Xia, et al.
Publicado: (2020) -
Diagnosis and Management of Preeclampsia: Suggested Guidance on the Use of Biomarkers
por: Costa, Maria Laura, et al.
Publicado: (2022)